Stock Market: British Investors Increase Short Position in Bally's
British fund Qube Research & Technologies has raised its short position in the shares of Bally's Intralot from 0.50% to 0.61%.
Stock Market: First Victory of Bally’s Against the Shorts
Bally’s Intralot shares have won their first significant battle against short-seller Qube Research, recovering to the brink of 1 euro due to stock buybacks.
Stock Exchange: Short Selling 'Burns' Bally's Intralot
Bally's Intralot's stock has fallen to its lowest levels since November due to increased short selling, particularly from Qube, resulting in a nearly 9% loss this year.
The short sellers of the last 6 years in the Stock Exchange - Which stocks are under scrutiny
The article discusses the continued presence of short selling in the Athens Stock Exchange despite a long-standing bull market, highlighting specific cases and overall market trends.
The Korean Man Who Wants to Defeat the Short-Sellers – From the 2.6 Billion Euro Deal to the Snag in Britain
Soo Kim, a hedge fund executive, faced unexpected regulatory challenges in the UK after his significant investment to merge Bally's and Intralot in a deal worth 2.6 billion euros.
Stock Market: The Risk for Bally’s Intralot
Bally’s Intralot's stock is teetering at the lower limit of a prolonged consolidation phase, starting the new week at 1.00 euro after dipping to 0.98 euro last Friday.
Stock Exchange: Why Bally’s Intralot Struggles to 'Breathe'
Bally’s Intralot's stock is declining towards the €1.00 support level amid underperformance against the General Index and insufficient backing from its major shareholder, compounded by strict regulatory frameworks in the UK.